Grundlæggende statistik
| CIK | 881695 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Palomar Medical Technologies Llc
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| February 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Palomar Medical Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 697529303 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| July 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 1-11177 PALOMAR MEDICAL TECHNOLOGIES, LLC (Exact name of registrant as speci |
|
| June 27, 2013 |
PMTI / Palomar Medical Technologies Llc / BROADWOOD PARTNERS, L.P. Passive Investment SC 13G/A 1 d139345313g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Palomar Medical Technologies, LLC (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 697529303 (CUSIP Number) June 24, 2013 (Date of Event Which Requires Filing of this Statement) Check the |
|
| June 25, 2013 |
As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. |
|
| June 25, 2013 |
S-8 POS 1 d557107ds8pos.htm S-8 POS AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. 33-87908 Registration No. 33-97710 Registration No. 333-18347 Registration No. 333-33390 Registration No. 333-55821 Registration No. 333-57403 Registration No. 333-57580 Registration No. 333-115719 Registration No. 333-144727 UNITED STATES SECURITIES AND EXCHAN |
|
| June 25, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. |
|
| June 25, 2013 |
S-8 POS Amendment No. 2 As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. 33-87908 Registration No. 33-97710 Registration No. 333-18347 Registration No. 333-33390 Registration No. 333-55821 Registration No. 333-57403 Registration No. 333-57580 Registration No. 333-115719 Registration No. 333-144727 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| June 25, 2013 |
S-8 POS 1 d557107ds8pos.htm S-8 POS AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. 33-87908 Registration No. 33-97710 Registration No. 333-18347 Registration No. 333-33390 Registration No. 333-55821 Registration No. 333-57403 Registration No. 333-57580 Registration No. 333-115719 Registration No. 333-144727 UNITED STATES SECURITIES AND EXCHAN |
|
| June 25, 2013 |
Certificate of Formation Commander Acquisition, LLC EX-3.1 Exhibit 3.1 Certificate of Formation of Commander Acquisition, LLC 1. Name. The name of the limited liability company is “Commander Acquisition, LLC” (the “Company”). The Company is a limited liability company organized under the Delaware Limited Liability Company Act, Title 6, Ch. 18, §§ 18-101, et seq. 2. Resident Agent and Address. The address of the Company’s registered office in the St |
|
| June 25, 2013 |
S-8 POS 1 d557107ds8pos.htm S-8 POS AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. 33-87908 Registration No. 33-97710 Registration No. 333-18347 Registration No. 333-33390 Registration No. 333-55821 Registration No. 333-57403 Registration No. 333-57580 Registration No. 333-115719 Registration No. 333-144727 UNITED STATES SECURITIES AND EXCHAN |
|
| June 25, 2013 |
As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. |
|
| June 25, 2013 |
As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. |
|
| June 25, 2013 |
S-8 POS 1 d557107ds8pos.htm S-8 POS AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. 33-87908 Registration No. 33-97710 Registration No. 333-18347 Registration No. 333-33390 Registration No. 333-55821 Registration No. 333-57403 Registration No. 333-57580 Registration No. 333-115719 Registration No. 333-144727 UNITED STATES SECURITIES AND EXCHAN |
|
| June 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2013 PALOMAR MEDICAL TECHNOLOGIES, LLC (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 32-0404990 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No. |
|
| June 25, 2013 |
As filed with the Securities and Exchange Commission on June 25, 2013 Registration No. |
|
| June 17, 2013 |
Filed by Palomar Medical Technologies, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b) under the Securities Exchange Act of 1934. Subject Company: Palomar Medical Technologies, Inc. Commission File No.: 333-187895 The following e-mail was first sent by Palomar Medical Technologies, Inc. to it employees on June 17, 2013: June 17, 2013 Benefit Qu |
|
| June 14, 2013 |
425 1 d554448d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or Other Jurisdictio |
|
| June 14, 2013 |
425 1 d554559d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2013 Cynosure, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51623 04-3125110 (State or Other Jurisdiction of Incorporati |
|
| June 14, 2013 |
8-K 1 d554448d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or Other Jurisdictio |
|
| June 10, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| June 10, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2013 Cynosure, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51623 04-3125110 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| June 10, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| June 10, 2013 |
Palomar Signs Memorandum of Understanding Regarding Settlement of Delaware Merger Litigation EX-99.1 Exhibit 99.1 Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 [email protected] Palomar Signs Memorandum of Understanding Regarding Settlement of Delaware Merger Litigation Burlington, MA– June 10, 2013 –Palomar Medical Technologies, Inc. (NASDAQ: PMTI) today announced that it has entered into a memorandum of understanding with plai |
|
| June 10, 2013 |
Palomar Signs Memorandum of Understanding Regarding Settlement of Delaware Merger Litigation EX-99.1 Exhibit 99.1 Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 [email protected] Palomar Signs Memorandum of Understanding Regarding Settlement of Delaware Merger Litigation Burlington, MA– June 10, 2013 –Palomar Medical Technologies, Inc. (NASDAQ: PMTI) today announced that it has entered into a memorandum of understanding with plai |
|
| June 10, 2013 |
Palomar Signs Memorandum of Understanding Regarding Settlement of Delaware Merger Litigation Exhibit 99.1 Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 [email protected] Palomar Signs Memorandum of Understanding Regarding Settlement of Delaware Merger Litigation Burlington, MA– June 10, 2013 –Palomar Medical Technologies, Inc. (NASDAQ: PMTI) today announced that it has entered into a memorandum of understanding with plaintiffs i |
|
| May 23, 2013 |
DEFM14A 1 d503926ddefm14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Regi |
|
| May 21, 2013 |
Filed by Cynosure, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Palomar Medical Technologies, Inc. Commission File No.: 333-187895 Cynosure’s CEO Presents at UBS Global Healthcare Conference (Transcript) May 21 2013 Executives Michael Davin—Chairman, President & CEO Timothy Baker—EVP & |
|
| May 16, 2013 |
Merger Prospectus - FORM 8-K/425 425 1 d539993d8k.htm FORM 8-K/425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or Other Jurisdic |
|
| May 16, 2013 |
EX-2.1 Exhibit 2.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and among CYNOSURE, INC., COMMANDER ACQUISITION, LLC and PALOMAR MEDICAL TECHNOLOGIES, INC. Dated as of May 15, 2013 TABLE OF CONTENTS ARTICLE I THE MERGER 2 1.1 Effective Time of the Merger. 2 1.2 Closing. 2 1.3 Effects of the Merger. 3 1.4 Managers and Officers of the Surviving Entity. 3 ARTICLE II CONVERSION OF SECURITIES 3 |
|
| May 16, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K/425 Form 8-K/425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| May 16, 2013 |
Merger Prospectus - FORM 8-K/425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2013 Cynosure, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51623 04-3125110 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| May 16, 2013 |
EX-2.1 Exhibit 2.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and among CYNOSURE, INC., COMMANDER ACQUISITION, LLC and PALOMAR MEDICAL TECHNOLOGIES, INC. Dated as of May 15, 2013 TABLE OF CONTENTS ARTICLE I THE MERGER 2 1.1 Effective Time of the Merger. 2 1.2 Closing. 2 1.3 Effects of the Merger. 3 1.4 Managers and Officers of the Surviving Entity. 3 ARTICLE II CONVERSION OF SECURITIES 3 |
|
| May 16, 2013 |
EX-2.1 Exhibit 2.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and among CYNOSURE, INC., COMMANDER ACQUISITION, LLC and PALOMAR MEDICAL TECHNOLOGIES, INC. Dated as of May 15, 2013 TABLE OF CONTENTS ARTICLE I THE MERGER 2 1.1 Effective Time of the Merger. 2 1.2 Closing. 2 1.3 Effects of the Merger. 3 1.4 Managers and Officers of the Surviving Entity. 3 ARTICLE II CONVERSION OF SECURITIES 3 |
|
| May 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended March 31, 2013 ¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 1-11177 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| May 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| May 2, 2013 |
PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2013 EX-99.1 Exhibit 99.1 NEWS RELEASE for May 2, 2013 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 [email protected] PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2013 BURLINGTON, MA (May 2, 2013)…Palomar Medical Technologies, Inc. (NASDAQ: PMTI), a global leader in laser and other light-based systems fo |
|
| May 2, 2013 |
PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2013 EX-99.1 Exhibit 99.1 NEWS RELEASE for May 2, 2013 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 [email protected] PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2013 BURLINGTON, MA (May 2, 2013)…Palomar Medical Technologies, Inc. (NASDAQ: PMTI), a global leader in laser and other light-based systems fo |
|
| May 2, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| April 30, 2013 |
425 1 d527472d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2013 Cynosure, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51623 04-3125110 (State or Other Jurisdiction of Incorporation |
|
| April 26, 2013 |
Annual Report - FORM 10-K AMENDMENT NO. 1 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: |
|
| April 24, 2013 |
Cynosure and Palomar Announce Date for Stockholder Meetings EX-99.1 Exhibit 99.1 Contacts: Scott Solomon Kerry McAnistan Vice President Investor Relations Assistant Sharon Merrill Associates, Inc. Palomar Medical Technologies, Inc. 617.542.5300 781-993-2411 [email protected] [email protected] Cynosure and Palomar Announce Date for Stockholder Meetings Westford, MA and Burlington, MA– April 24, 2013 – Cynosure, Inc. (NASDAQ: CYNO) and Palomar M |
|
| April 24, 2013 |
Cynosure and Palomar Announce Date for Stockholder Meetings Exhibit 99.1 Contacts: Scott Solomon Kerry McAnistan Vice President Investor Relations Assistant Sharon Merrill Associates, Inc. Palomar Medical Technologies, Inc. 617.542.5300 781-993-2411 [email protected] [email protected] Cynosure and Palomar Announce Date for Stockholder Meetings Westford, MA and Burlington, MA– April 24, 2013 – Cynosure, Inc. (NASDAQ: CYNO) and Palomar Medical T |
|
| April 24, 2013 |
425 1 d526730d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or Other Jurisdicti |
|
| April 24, 2013 |
425 1 d526631d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2013 Cynosure, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51623 04-3125110 (State or Other Jurisdiction of Incorporat |
|
| April 24, 2013 |
425 1 d526673d425.htm 425 Filed by Palomar Medical Technologies, Inc. pursuant to Rule 425 under the Securities Act and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934. Subject Company: Palomar Medical Technologies, Inc. Commission File No.: 001-11177 To: Palomar Employees From: Paul S. Weiner Date: April 24, 2013 Re: Effect of Cynosure Acquisition on Palomar Employe |
|
| April 24, 2013 |
Cynosure and Palomar Announce Date for Stockholder Meetings EX-99.1 Exhibit 99.1 Contacts: Scott Solomon Kerry McAnistan Vice President Investor Relations Assistant Sharon Merrill Associates, Inc. Palomar Medical Technologies, Inc. 617.542.5300 781-993-2411 [email protected] [email protected] Cynosure and Palomar Announce Date for Stockholder Meetings Westford, MA and Burlington, MA– April 24, 2013 – Cynosure, Inc. (NASDAQ: CYNO) and Palomar M |
|
| April 24, 2013 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| March 21, 2013 |
PMTI / Palomar Medical Technologies Llc / CYNOSURE INC - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Palomar Medical Technologies, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 697529303 (CUSIP Number) Benjamin A. Kaplan, Esquire Senior Vice President and General Counsel Cynosure, Inc. 5 Carlisl |
|
| March 21, 2013 |
CYNO / Cynosure, Inc. / PALOMAR MEDICAL TECHNOLOGIES INC - SCHEDULE 13D Activist Investment SC 13D 1 d507254dsc13d.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. )* Cynosure, Inc. (Name of Issuer) Class A Common Stock, $0.001 per share (Title of Class of Securities) 232577205 (CUSIP Number) Pal |
|
| March 21, 2013 |
Filed by Palomar Medical Technologies, Inc. pursuant to Rule 425 under the Securities Act and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Palomar Medical Technologies, Inc. Commission File No.: 001-11177 The following letter was sent to customers of Palomar Medical Technologies, Inc. on March 21, 2013: Dear Customer: As you may be aware, on March |
|
| March 18, 2013 |
EX-10.4 Exhibit 10.4 Paul S. Weiner 16 Mayo Road Wellesley, MA 02482 Dear Mr. Weiner: Reference is made to your employment agreement with Palomar Medical Technologies, Inc. (the “Company”) dated July 1, 2001, as amended by amendments dated May 19, 2010 and May 15, 2012 (together, the “Employment Agreement”). As you know, in connection with the proposed merger of the Company and Cynosure, Inc., the |
|
| March 18, 2013 |
EX-2.1 Table of Contents Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among CYNOSURE, INC., COMMANDER ACQUISITION CORP. and PALOMAR MEDICAL TECHNOLOGIES, INC. Dated as of March 17, 2013 Table of Contents TABLE OF CONTENTS ARTICLE I THE MERGER 1 1.1 Effective Time of the Merger 1 1.2 Closing 1 1.3 Effects of the Merger 2 1.4 Directors and Officers of the Surviving Corporation 2 ARTICLE II CONVER |
|
| March 18, 2013 |
EX-2.1 Table of Contents Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among CYNOSURE, INC., COMMANDER ACQUISITION CORP. and PALOMAR MEDICAL TECHNOLOGIES, INC. Dated as of March 17, 2013 Table of Contents TABLE OF CONTENTS ARTICLE I THE MERGER 1 1.1 Effective Time of the Merger 1 1.2 Closing 1 1.3 Effects of the Merger 2 1.4 Directors and Officers of the Surviving Corporation 2 ARTICLE II CONVER |
|
| March 18, 2013 |
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies Exhibit 99.2 Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies March 18, 2013 Forward-Looking Statements With the exception of the historical information contained in this presentation, the matters described herein contain forward-looking statements, including, but not limited to, statements relating to long-term growth and profitability, projected synergies, the expectat |
|
| March 18, 2013 |
CYNOSURE, INC. EMPLOYMENT AGREEMENT EX-10.3 Exhibit 10.3 CYNOSURE, INC. EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of the 17th day of March, 2013 by and between Cynosure, Inc., a Delaware corporation (the “Company”) and Joseph P. Caruso (“Executive”). BACKGROUND A. Palomar Medical Technologies, Inc. (“Palomar”), the Company, and a wholly owned subsidiary of the Company (the “Merger |
|
| March 18, 2013 |
EX-10.1 Exhibit 10.1 COMPANY STOCKHOLDER AGREEMENT This Stockholder Agreement (this “Agreement”), dated as of March 17, 2013, is entered into by and between Cynosure, Inc., a Delaware corporation (the “Buyer”), and the undersigned stockholder (“Stockholder”) of Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”). WHEREAS, concurrently with the execution of this Agreement, th |
|
| March 18, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| March 18, 2013 |
EX-99.1 4 d503688dex991.htm EX-99.1 Exhibit 99.1 Contacts: Scott Solomon Kerry McAnistan Vice President Investor Relations Assistant Sharon Merrill Associates, Inc. Palomar Medical Technologies, Inc. 617.542.5300 781-993-2411 [email protected] [email protected] Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies • Creates One of World’s Premier Aesthetic Laser |
|
| March 18, 2013 |
AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT EX-4.1 Exhibit 4.1 EXECUTION VERSION AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT This AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT (this “Amendment”) is entered into as of March 17, 2013, between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a limited liability trust company, as Rights Agent (t |
|
| March 18, 2013 |
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies EX-99.3 10 d503633dex993.htm EX-99.3 Exhibit 99.3 Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies March 18, 2013 Forward-Looking Statements With the exception of the historical information contained in this presentation, the matters described herein contain forward-looking statements, including, but not limited to, statements relating to long-term growth and profitabili |
|
| March 18, 2013 |
AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT EX-4.1 Exhibit 4.1 EXECUTION VERSION AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT This AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT (this “Amendment”) is entered into as of March 17, 2013, between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a limited liability trust company, as Rights Agent (t |
|
| March 18, 2013 |
THIRD AMENDMENT TO EMPLOYMENT AGREEMENT EX-10.3 Exhibit 10.3 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This shall serve as the Third Amendment to the Employment Agreement (this “Amendment”) entered into as of this 17 day of March, 2013, between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and Joseph P. Caruso, an individual (the “Executive”). WHEREAS, the Company and the Executive are parties to a certain Em |
|
| March 18, 2013 |
- FORM 8-A/A (AMENDMENT NO. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-A/A Amendment No. 1 For Registration of Certain Classes of Securities Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 PALOMAR MEDICAL TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 04-3128178 (State of incorporation or organization) (I.R.S. Employer Identificat |
|
| March 18, 2013 |
EX-2.1 Table of Contents Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among CYNOSURE, INC., COMMANDER ACQUISITION CORP. and PALOMAR MEDICAL TECHNOLOGIES, INC. Dated as of March 17, 2013 Table of Contents TABLE OF CONTENTS ARTICLE I THE MERGER 1 1.1 Effective Time of the Merger 1 1.2 Closing 1 1.3 Effects of the Merger 2 1.4 Directors and Officers of the Surviving Corporation 2 ARTICLE II CONVER |
|
| March 18, 2013 |
EX-10.2 Exhibit 10.2 BUYER STOCKHOLDER AGREEMENT This Stockholder Agreement (this “Agreement”), dated as of March 17, 2013, is entered into by and between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and the undersigned stockholder (“Stockholder”) of Cynosure, Inc., a Delaware corporation (the “Buyer”). WHEREAS, concurrently with the execution of this Agreement, the |
|
| March 18, 2013 |
THIRD AMENDMENT TO EMPLOYMENT AGREEMENT EX-10.3 Exhibit 10.3 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This shall serve as the Third Amendment to the Employment Agreement (this “Amendment”) entered into as of this 17 day of March, 2013, between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and Joseph P. Caruso, an individual (the “Executive”). WHEREAS, the Company and the Executive are parties to a certain Em |
|
| March 18, 2013 |
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies EX-99.3 Exhibit 99.3 Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies March 18, 2013 Forward-Looking Statements With the exception of the historical information contained in this presentation, the matters described herein contain forward-looking statements, including, but not limited to, statements relating to long-term growth and profitability, projected synergies, the |
|
| March 18, 2013 |
425 1 d503688d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2013 Cynosure, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51623 04-3125110 (State or Other Jurisdiction of Incorporat |
|
| March 18, 2013 |
THOMSON REUTERS STREETEVENTS | EX-99.2 Exhibit 99.2 1 THOMSON REUTERS STREETEVENTS | www.streetevents.com | Contact Us © 2013 Thomson Reuters. All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. ‘Thomson Reuters’ and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its |
|
| March 18, 2013 |
EX-10.1 Exhibit 10.1 COMPANY STOCKHOLDER AGREEMENT This Stockholder Agreement (this “Agreement”), dated as of March 17, 2013, is entered into by and between Cynosure, Inc., a Delaware corporation (the “Buyer”), and the undersigned stockholder (“Stockholder”) of Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”). WHEREAS, concurrently with the execution of this Agreement, th |
|
| March 18, 2013 |
EX-99.1 Exhibit 99.1 Contacts: Scott Solomon Kerry McAnistan Vice President Investor Relations Assistant Sharon Merrill Associates, Inc. Palomar Medical Technologies, Inc. 617.542.5300 781-993-2411 [email protected] [email protected] Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies • Creates One of World’s Premier Aesthetic Laser and Light-Based Companies • |
|
| March 18, 2013 |
EX-99.1 Exhibit 99.1 Contacts: Scott Solomon Kerry McAnistan Vice President Investor Relations Assistant Sharon Merrill Associates, Inc. Palomar Medical Technologies, Inc. 617.542.5300 781-993-2411 [email protected] [email protected] Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies • Creates One of World’s Premier Aesthetic Laser and Light-Based Companies • |
|
| March 18, 2013 |
THOMSON REUTERS STREETEVENTS | EX-99.2 Exhibit 99.2 1 THOMSON REUTERS STREETEVENTS | www.streetevents.com | Contact Us © 2013 Thomson Reuters. All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. ‘Thomson Reuters’ and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its |
|
| March 18, 2013 |
THOMSON REUTERS STREETEVENTS | EX-99.3 Exhibit 99.3 1 THOMSON REUTERS STREETEVENTS | www.streetevents.com | Contact Us © 2013 Thomson Reuters. All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. ‘Thomson Reuters’ and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its |
|
| March 18, 2013 |
425 1 d503633d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2013 PALOMAR MEDICAL TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or Other Jurisdicti |
|
| March 18, 2013 |
EX-10.2 Exhibit 10.2 BUYER STOCKHOLDER AGREEMENT This Stockholder Agreement (this “Agreement”), dated as of March 17, 2013, is entered into by and between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and the undersigned stockholder (“Stockholder”) of Cynosure, Inc., a Delaware corporation (the “Buyer”). WHEREAS, concurrently with the execution of this Agreement, the |
|
| March 18, 2013 |
EX-10.4 Exhibit 10.4 Paul S. Weiner 16 Mayo Road Wellesley, MA 02482 Dear Mr. Weiner: Reference is made to your employment agreement with Palomar Medical Technologies, Inc. (the “Company”) dated July 1, 2001, as amended by amendments dated May 19, 2010 and May 15, 2012 (together, the “Employment Agreement”). As you know, in connection with the proposed merger of the Company and Cynosure, Inc., the |
|
| March 14, 2013 |
PALOMAR MEDICAL TECHNOLOGIES, INC. Restricted Stock Agreement NOTICE OF GRANT PALOMAR MEDICAL TECHNOLOGIES, INC. Restricted Stock Agreement NOTICE OF GRANT This Restricted Stock Agreement (this "Agreement") is made as of the Agreement Date between Palomar Medical Technologies, Inc. (the "Company"), a Delaware corporation, and the Recipient. I. Agreement Date Date: II. Recipient Information Recipient: III. Grant Information Grant Date: Shares of Restricted Stock: IV. Vesting |
|
| March 14, 2013 |
EXECUTIVE OFFICER LEVEL CHIEF FINANCIAL OFFICER Palomar Medical Technologies, Inc. |
|
| March 14, 2013 |
EXECUTIVE OFFICER LEVEL CHIEF EXECUTIVE OFFICER Palomar Medical Technologies, Inc. |
|
| March 14, 2013 |
PALOMAR MEDICAL TECHNOLOGIES, INC. Restricted Stock Agreement for Employees with Employment Agreements Performance Based Vesting NOTICE OF GRANT This Restricted Stock Agreement (this "Agreement") is made as of the Agreement Date between Palomar Medical Technologies, Inc. (the "Company"), a Delaware corporation, and the Recipient. I. Agreement Date Date: December 3, 2012 II. Recipient Information R |
|
| March 14, 2013 |
PALOMAR MEDICAL TECHNOLOGIES, INC. Restricted Stock Agreement NOTICE OF GRANT PALOMAR MEDICAL TECHNOLOGIES, INC. Restricted Stock Agreement NOTICE OF GRANT This Restricted Stock Agreement (this "Agreement") is made as of the Agreement Date between Palomar Medical Technologies, Inc. (the "Company"), a Delaware corporation, and the Recipient. I. Agreement Date Date: II. Recipient Information Recipient: III. Grant Information Grant Date: Shares of Restricted Stock: IV. Vesting |
|
| March 14, 2013 |
10-K 1 form10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-11177 PALOMAR MED |
|
| March 14, 2013 |
Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of the Registrant Name of Subsidiary Jurisdiction of Organization Palomar Medical Technologies, Inc. Delaware Palomar Medical Products, Inc. Delaware Palomar Medical Technologies B.V. The Netherlands Palomar Medical Technologies (Australia) Pty Ltd Australia Palomar Japan K.K. Japan Palomar Medical Technologies GmbH Germany Palomar Medical Technologies S.L.U. Spain |
|
| February 14, 2013 |
PMTI / Palomar Medical Technologies Llc / BROADWOOD PARTNERS, L.P. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 11, 2013 |
PMTI / Palomar Medical Technologies Llc / VANGUARD GROUP INC Passive Investment palomarmedicaltechnolog.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Palomar Medical Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 697529303 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check |
|
| February 8, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 5, 2013 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or other jurisdic-tion of incorporation) (Commission File N |
|
| February 7, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2013 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission File Number) 04- |
|
| February 7, 2013 |
NEWS RELEASE for February 7, 2013 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. |
|
| November 8, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended September 30, 2012 ¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 1-11177 PALOMAR MEDICAL TECHNOLOGIES, |
|
| October 25, 2012 |
EX-99.1 2 ex99.htm NEWS RELEASE for October 25, 2012 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 [email protected] PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR THIRD QUARTER 2012 BURLINGTON, MA (October 25, 2012)…Palomar Medical Technologies, Inc. (NASDAQ: PMTI), a global leader in laser and other light-based sy |
|
| October 25, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission File Number) 04- |
|
| August 8, 2012 |
SECOND AMENDED AND RESTATED BY-LAWS AMENDED ON JULY 24, 2012 PALOMAR MEDICAL TECHNOLOGIES, INC. SECOND AMENDED AND RESTATED BY-LAWS AMENDED ON JULY 24, 2012 OF PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| August 8, 2012 |
May 15, 2012 Joseph P. Caruso 30 Zachary Lane Reading, MA 01867 Dear Mr. Caruso: Reference is made to your employment agreement with Palomar Medical Technologies, Inc. (the “Company”) dated July 1, 2001 (the “Agreement”) and the amendment thereto dated May 19, 2010 (the “Amendment”). By this letter, the Company wishes to correct certain drafting errors in the Agreement and the Amendment and to cla |
|
| August 8, 2012 |
10-Q 1 form10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended June 30, 2012 ¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 1-11177 PALOMAR MEDICAL |
|
| August 8, 2012 |
May 15, 2012 Paul S. Weiner 16 Mayo Road Wellesley, MA 02482 Dear Mr. Weiner: Reference is made to your employment agreement with Palomar Medical Technologies, Inc. (the “Company”) dated July 1, 2001 (the “Agreement”) and the amendment thereto dated May 19, 2010 (the “Amendment”). By this letter, the Company wishes to correct certain drafting errors in the Agreement and the Amendment and to clarif |
|
| July 26, 2012 |
NEWS RELEASE for July 26, 2012 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. |
|
| July 26, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 26, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission File Number) 04-312 |
|
| July 25, 2012 |
8-K 1 form8k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission Fi |
|
| July 25, 2012 |
PALOMAR MEDICAL TECHNOLOGIES, INC. Amendment to Second Amended and Restated Bylaws PALOMAR MEDICAL TECHNOLOGIES, INC. Amendment to Second Amended and Restated Bylaws The Second Amended and Restated Bylaws of Palomar Medical Technologies, Inc., specifically Article 1, Section 9 shall be amended by deleting section 1.9 in its entirety and replacing it with the following new section 1.9: 1.9 Action at Meeting. (a) General Matters. When a quorum is present at any meeting, any matter |
|
| May 22, 2012 |
Case 1:12-cv-10915 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ) PALOMAR MEDICAL ) TECHNOLOGIES, INC. |
|
| May 22, 2012 |
Financial Statements and Exhibits, Other Events SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 22, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission File Number) 04-3128 |
|
| May 22, 2012 |
FOR RELEASE TUESDAY, MAY 22, 2012 at 10:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. |
|
| May 18, 2012 |
Submission of Matters to a Vote of Security Holders SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 18, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission File Number) 04-3128 |
|
| May 8, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarter Ended March 31, 2012 ¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 1-11177 PALOMAR MEDICAL TECHNOLOGIES, INC. |
|
| April 26, 2012 |
PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2012 NEWS RELEASE for April 26, 2012 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. |
|
| April 26, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 26, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission File Number) 04-31 |
|
| April 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 12, 2012 |
SENIOR STRATEGIC ADVISOR AGREEMENT Exhibit 10.1 SENIOR STRATEGIC ADVISOR AGREEMENT THIS AGREEMENT is made by and between Palomar Medical Technologies, Inc. (hereafter “Company”), and Louis P. (Dan) Valente of 44 Concord Rd, Weston, MA 02493 (hereafter “Advisor”), commencing on 3/9/12 (“Effective Date”). WHEREAS, Advisor represents he has the ability and experience to render strategic advisory services to Company and desires to prov |
|
| March 12, 2012 |
Subsidiaries of the Registrant Exhibit 21 Subsidiaries of the Registrant Name of Subsidiary Jurisdiction of Organization Palomar Medical Technologies, Inc. Delaware Palomar Medical Products, Inc. Delaware Palomar Medical Technologies B.V. The Netherlands Palomar Medical Technologies (Australia) Pty Ltd Australia Palomar Japan K.K. Japan Palomar Medical Technologies GmbH Germany Palomar Medical Technologies S.L.U. Spain |
|
| March 12, 2012 |
10-K 1 form10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-11177 PALOMAR MED |
|
| February 10, 2012 |
8-K 1 form8k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 7, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission |
|
| February 10, 2012 |
EXECUTIVE OFFICER LEVEL CHIEF EXECUTIVE OFFICER Palomar Medical Technologies, Inc. |
|
| February 10, 2012 |
PMTI / Palomar Medical Technologies Llc / DRILL CRAIG A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2012 |
EXECUTIVE OFFICER LEVEL CHIEF FINANCIAL OFFICER Palomar Medical Technologies, Inc. |
|
| February 9, 2012 |
PMTI / Palomar Medical Technologies Llc / VANGUARD GROUP INC Passive Investment SC 13G 1 palomarmedicaltechnologiesin.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:0 )* Name of issuer: Palomar Medical Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 697529303 Date of Event Which Requires Filing of this Statement: December 31, 2011 Check the appropriate box to designa |
|
| February 9, 2012 |
8-K 1 form8k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2012 Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdic- tion of incorporation) 1-11177 (Commission |
|
| February 9, 2012 |
NEWS RELEASE for February 9, 2012 at 8:00AM Eastern Time Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. |
|
| January 4, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K/A 1 form8ka.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2012 (September 15, 2011) Palomar Medical Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 1-11177 04-3128178 (State or |
|
| January 4, 2012 |
SETTLEMENT AGREEMENT THIS SETTLEMENT AGREEMENT (this “Agreement”) is made and entered into as of the 15th day of September, 2011 (the “Effective Date”) by and among Palomar Medical Technologies, Inc. |
